Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04745351 · TERMINATED
Trial details
- NCT number
- NCT04745351
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2022-04-20
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.